Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lindsy Forbess

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Rheumatic Diseases Clinics of North America|November 18, 2014
Polyarteritis nodosaLindsy Forbess, Serguei Bannykh
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2016
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia RheumaticaLindsay Lally, Lindsy Forbess, Christopher Hatzis, et al.
ACR Open Rheumatology|July 1, 2026
Clinical Images: Skin manifestations and radiographic findings of anti-SAE1 positive dermatomyositisAmara Seng, George Matcuk, Wonwoo Shon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 17, 2025
Loss of TRIM21 drives UVB-induced systemic inflammation by regulating DNA-sensing pathwaysGantsetseg Tumurkhuu, Graziela Perri, Richard Moore, et al.
Journal of Autoimmunity|March 21, 2017
MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLESiobhán Smith, Thilini Fernando, Pei Wen Wu, et al.
Seminars in Arthritis and Rheumatism|June 9, 2018
Arterial lesions in giant cell arteritis: A longitudinal studyTanaz A Kermani, Sehriban Diab, Antoine G Sreih, et al.
JCI Insight|August 10, 2018
IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammationSiobhan Smith, Pei Wen Wu, Jane J Seo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2020
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2Oskar Schnappauf, Natalia Sampaio Moura, Ivona Aksentijevich, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Annals of the Rheumatic Diseases|March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Rheumatic Diseases Clinics of North America|November 18, 2014
Polyarteritis nodosaLindsy Forbess, Serguei Bannykh
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2016
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia RheumaticaLindsay Lally, Lindsy Forbess, Christopher Hatzis, et al.
ACR Open Rheumatology|July 1, 2026
Clinical Images: Skin manifestations and radiographic findings of anti-SAE1 positive dermatomyositisAmara Seng, George Matcuk, Wonwoo Shon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 17, 2025
Loss of TRIM21 drives UVB-induced systemic inflammation by regulating DNA-sensing pathwaysGantsetseg Tumurkhuu, Graziela Perri, Richard Moore, et al.
Journal of Autoimmunity|March 21, 2017
MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLESiobhán Smith, Thilini Fernando, Pei Wen Wu, et al.
Seminars in Arthritis and Rheumatism|June 9, 2018
Arterial lesions in giant cell arteritis: A longitudinal studyTanaz A Kermani, Sehriban Diab, Antoine G Sreih, et al.
JCI Insight|August 10, 2018
IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammationSiobhan Smith, Pei Wen Wu, Jane J Seo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2020
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2Oskar Schnappauf, Natalia Sampaio Moura, Ivona Aksentijevich, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Annals of the Rheumatic Diseases|March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, et al.
Pageof 2